Entrada Therapeutics Cash Flow Statement (2020-2026) | TRDA

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-9.90M-34.46M-47.36M-21.67M-23.18M-25.14M-24.63M-6.67M-25.93M35.46M-9.50M23.50M54.99M-14.03M1.13M-17.35M-43.12M-44.13M-39.17M-39.72M
Depreciation and Depletion (Quarter)
0.30M0.30M0.30M0.39M0.50M0.50M0.53M0.54M0.70M0.80M0.70M0.93M0.90M0.90M1.02M0.90M1.10M1.20M0.90M0.80M
Share-based Compensation (Quarter)
0.58M1.46M1.79M-1.79M7.01M-7.01M2.75M3.12M3.40M68.31M3.73M4.62M4.86M4.70M5.09M5.05M5.12M4.36M4.74M
Deferred Taxes (Quarter)
0.06M-0.22M0.06M
Cash from Operations (Quarter)
-7.91M-14.07M-20.54M-20.99M-18.01M-27.48M-27.30M203.40M-35.09M-24.49M-4.01M-25.52M39.83M-24.27M-31.61M-38.51M-29.49M-28.31M-32.20M-41.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.14M-0.14M0.03M0.10M0.24M1.69M1.85M2.00M2.04M2.26M3.21M2.51M1.34M0.96M0.74M0.63M0.55M
Depreciation & Amortization (CF) (Quarter)
0.30M0.30M0.30M0.39M0.50M0.50M0.53M0.54M0.70M0.80M0.70M0.93M0.90M0.90M1.02M0.90M1.10M1.20M0.90M0.80M
Change in Working Capital
Change in Account Payables (Quarter)
0.50M0.08M-1.03M2.06M1.54M-2.91M4.59M0.53M-4.38M-1.36M2.41M-0.66M-0.89M-0.31M2.85M-1.91M-0.32M1.31M-0.88M0.64M
Change in Accured Expenses (Quarter)
0.58M2.06M1.82M-1.53M0.73M6.90M-4.34M4.11M-5.05M2.80M1.96M-2.52M1.62M3.04M-0.42M-5.46M4.31M3.74M2.15M-5.95M
Change in Taxes (Quarter)
7.36M-7.36M4.02M1.83M-1.74M-1.86M-1.58M0.14M-0.80M0.62M-0.62M
Other Working Capital Changes (Quarter)
-1.53M-1.94M-1.96M-2.01M-1.95M-6.79M-3.96M0.84M-1.80M-1.99M-3.13M-2.11M-2.21M-2.25M-2.34M-1.47M-1.18M
Investing Activities
Capital Expenditures (Quarter)
1.54M-0.53M2.66M0.39M-0.39M2.18M-2.09M8.63M-7.74M3.75M0.98M0.12M1.77M-3.93M5.20M0.11M-0.19M-0.04M0.12M
Change in Acquisitions & Divestments (Quarter)
1.71M25.00M30.00M19.50M63.00M28.39M74.50M108.54M123.92M87.36M83.31M118.50M85.95M50.63M75.50M47.38M38.86M
Cash from Investing Activities (Quarter)
-1.54M-0.81M-1.32M-181.53M24.23M-10.13M18.79M-40.44M-113.26M-3.74M19.04M26.15M-24.38M-82.93M53.37M4.78M33.80M49.11M29.12M26.99M
Financing Activities
Other financing activities (Quarter)
0.21M0.11M0.06M0.05M-0.05M0.12M0.07M0.13M0.26M0.37M-0.31M0.21M1.10M-1.05M0.31M0.35M0.02M0.01M0.08M0.10M
Change in Capital Stock
Shares Issued (Quarter)
0.14M0.11M
Net Equity Issued and Repurchased (Quarter)
-0.42M19.41M100.00M-0.39M
Misc.
Cash from Financing Activities (Quarter)
0.21M0.11M190.75M0.05M0.01M0.06M0.36M19.54M0.44M0.37M0.69M0.21M101.37M-0.01M1.40M0.35M0.34M0.01M0.19M0.10M
Change in Cash (Quarter)
-9.24M-14.78M168.89M-202.47M6.23M-37.56M-8.15M182.49M-147.91M-27.86M15.72M0.83M116.82M-107.20M23.16M-33.37M4.64M20.80M-2.89M-14.61M
Free Cash Flow (Quarter)
-9.45M-13.55M-23.20M-21.38M-17.62M-29.66M-25.21M194.77M-27.35M-28.24M-4.99M-25.63M38.06M-20.34M-36.81M-38.62M-29.30M-28.28M-32.32M-41.70M
Net Cash Flow (Quarter)
-9.24M-14.78M168.89M-202.47M6.23M-37.56M-8.15M182.49M-147.91M-27.86M15.72M0.83M116.82M-107.20M23.16M-33.37M4.64M20.80M-2.89M-14.61M